With a newly developed method that compares AI-generated protein sequences with naturally occurring ones, function- and ...
The proliferation of wireless technology raised concerns about electromagnetic radiation's biological effects, including oxidative stress and potential ...
Discover Canaan Inc. Statistics with fresh insights, growth, and market trends that reveal its hidden potential and future trajectory.
Discover key Cipher Mining Statistics, trends, and growth data driving revenue, AI expansion, and profitability insights for ...
Tech firms are investing billions to build massive AI data centers across the U.S. From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your ...
What has been going down on the University of Nebraska Medical Center campus in Omaha soon will start to go up. Project Health, the new $2.19 billion academic medical center planned on the University ...
Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin. American Transmission Co. is planning a $1.4 billion ...
On Wednesday, Wikimedia Deutschland announced a new database that will make Wikipedia’s wealth of knowledge more accessible to AI models. Called the Wikidata Embedding Project, the system applies a ...
Wikipedia’s sister project Wikidata just got a new database that is easier for AI models to ingest. Wikipedia’s sister project Wikidata just got a new database that is easier for AI models to ingest ...
Wikimedia, the nonprofit behind Wikipedia and sister sites like Wikimedia Commons and Wikidata, just made it easier for AI models to tap into its massive knowledge base. Wikimedia Deutschland, the ...
Data support the potential therapeutic efficacy of ROC-101; justify further development via a Phase 2, proof-of-concept trial in patients with PAH or ILD-PH slated to begin Q4 2025 NATICK, Mass., Sept ...
New preclinical data demonstrate deeper IgA reduction and a longer half-life compared to first-generation anti-APRIL monoclonal antibody CLYM116 Phase 1 trial initiation expected in Q4 2025, with ...